Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its ...
Zacks Investment Research on MSN
Tandem Diabetes Care, Inc. (TNDM) reports Q4 loss, tops revenue estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.44 per share a year ago. These ...
StockStory.org on MSN
Tandem Diabetes’s (NASDAQ:TNDM) Q4 CY2025 sales top estimates
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q4 CY2025, with sales up 15% year on year to $290.4 million ...
Tandem bicycles are great for allowing couples or friends to ride together, but they're not exactly conducive to riding by yourself. While you could just buy a tandem and a solo bike, one couple ...
Though no-moat Tandem’s TNDM second-quarter results provided slight sequential improvement, top-line growth remains under pressure from competitive forces as well as patient adoption patterns ahead of ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings this Wednesday after the bell. Here’s what investors should know. Tandem Diabetes beat analysts’ revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results